Laczi F, Mezei G, Julesz J, Lázló F A
Int J Clin Pharmacol Ther Toxicol. 1981 Feb;19(2):63-8.
The effects of 1-deamino-8-D-arginine vasopressin (DDAVP), 1-deamino-4-valin-8-D-arginine vasopressin (DVDAVP) and 8-arginine vasopressin (AVP) on water metabolism have been examined in 18 patients suffering from central diabetes insipidus. The hormone derivatives were sublingually administered. It was established that DDAVP and DVDAVP significantly reduced diuresis and increased urine osmolarity. DVDAVP was found to be more effective than DDAVP. AVP administered in equal doses had no significant effect on water metabolism. The duration of the action of sublingually administered DDAVP was 12 hrs; after dosing DVDAVP the effect lasted even 6 hrs. During one week of DDAVP administration, the accumulation of the drug was indicated by the gradual decrease of diuresis and the increase of the urine osmolarity. The sublingual administration of both DDAVP and DVDAVP tablets (3 X 30 micrograms/day) had an adequate therapeutic effect.
对18例中枢性尿崩症患者研究了1-去氨基-8-D-精氨酸加压素(DDAVP)、1-去氨基-4-缬氨酸-8-D-精氨酸加压素(DVDAVP)和8-精氨酸加压素(AVP)对水代谢的影响。这些激素衍生物采用舌下给药。结果表明,DDAVP和DVDAVP均能显著减少尿量并提高尿渗透压。发现DVDAVP比DDAVP更有效。同等剂量的AVP对水代谢无显著影响。舌下给药的DDAVP作用持续时间为12小时;给予DVDAVP后,作用甚至持续6小时。在给予DDAVP的一周内,尿量逐渐减少和尿渗透压升高表明药物在体内蓄积。舌下给予DDAVP和DVDAVP片剂(3×30微克/天)均有足够的治疗效果。